7-(2-aminopyridin-4-yl)-N-(3-cyanophenyl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide

ID: ALA4781458

PubChem CID: 162664225

Max Phase: Preclinical

Molecular Formula: C22H19N5O2

Molecular Weight: 385.43

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1cccc(NC(=O)N2CCOc3ccc(-c4ccnc(N)c4)cc3C2)c1

Standard InChI:  InChI=1S/C22H19N5O2/c23-13-15-2-1-3-19(10-15)26-22(28)27-8-9-29-20-5-4-16(11-18(20)14-27)17-6-7-25-21(24)12-17/h1-7,10-12H,8-9,14H2,(H2,24,25)(H,26,28)

Standard InChI Key:  PWFUQVAPDVWAQX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    4.2166  -29.9348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2155  -30.7543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9235  -31.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9217  -29.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5093  -31.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8017  -30.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0941  -31.1591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0930  -31.9772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8054  -32.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5100  -31.9764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6351  -30.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6303  -29.9312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2713  -29.4102    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2851  -31.2610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0758  -29.5829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0881  -31.0698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4371  -30.3222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6045  -31.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3141  -32.4671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4112  -31.5728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9275  -32.2062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6344  -32.9686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1500  -33.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9576  -33.4715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2470  -32.7028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7296  -32.0730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3869  -30.7496    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0524  -32.5679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8586  -32.4346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3 11  2  0
 12  4  2  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  2  5  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
  7 27  1  0
 28 29  3  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4781458

    ---

Associated Targets(Human)

GPR142 Tchem Probable G-protein coupled receptor 142 (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr142 Probable G-protein coupled receptor 142 (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1539AlogP: 3.63#Rotatable Bonds: 2
Polar Surface Area: 104.27Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.02CX Basic pKa: 6.89CX LogP: 2.77CX LogD: 2.66
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.70Np Likeness Score: -1.43

References

1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S.  (2016)  Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes.,  26  (12.0): [PMID:27240550] [10.1016/j.bmcl.2016.04.018]

Source